H.R. 1620: Finn Sawyer Access to Cancer Testing Act

H.R. 1620 is a federal bill in the 119th Congress. Currently, advanced cancer diagnostic tests such as microarray analysis, DNA and RNA sequencing, and whole-exome sequencing may not be consistently covered by Medicare, Medicaid, or the Children's Health Insurance Program (CHIP). This bill changes that by… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.